How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)

GAPG van Mastrigt, M Hiligsmann… - Expert review of …, 2016 - Taylor & Francis
Introduction: Systematic reviews of economic evaluations are useful for synthesizing
economic evidence about health interventions and for informing evidence-based decisions …

Economic evaluations of nonpharmacological treatments for drug‐resistant epilepsy: A systematic review

HY Chan, LMM Janssen, BFM Wijnen… - …, 2023 - Wiley Online Library
This study was undertaken to systematically identify and critically appraise all published full
economic evaluations assessing the cost‐effectiveness of nonpharmacological interventions …

Reasons for not having epilepsy surgery

A Khoo, J de Tisi, S Mannan, AG O'Keeffe… - …, 2021 - Wiley Online Library
Objective This study was undertaken to determine reasons for adults with drug‐resistant
focal epilepsy who undergo presurgical evaluation not proceeding with surgery, and to …

Maternal carbamazepine alters fetal neuroendocrine-cytokines axis

RG Ahmed, AW El-Gareib - Toxicology, 2017 - Elsevier
This study detected the impact of maternal carbamazepine (CBZ) on the fetal
neuroendocrine-cytokines axis. 25 or 50 mg/kg of CBZ was intraperitoneally administrated to …

Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital setting

JP Ney, K Gururangan, J Parvizi - Journal of Medical Economics, 2021 - Taylor & Francis
Aims Potentially life-threatening diagnosis of non-convulsive status epilepticus (NCSE) can
only be confirmed with electroencephalography (EEG). When access to EEG is limited …

Nanocage encapsulation improves antiepileptic efficiency of phenytoin

J Zhao, Z Ye, J Yang, Q Zhang, W Shan, X Wang… - Biomaterials, 2020 - Elsevier
More than 30% of patients with epilepsy progress to drug-resistant epilepsy, leading to a
significant increase in morbidity and mortality of epilepsy. The limitation of epileptic drug to …

Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review

A Kitschen, M Aleknonytė‐Resch… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Approximately 30% of epilepsy patients develop a drug‐refractory
epilepsy, that is, seizures cannot be controlled with antiepileptic drugs. Surgery has been …

The function of NF-kappa B during epilepsy, a potential therapeutic target

M Cai, W Lin - Frontiers in neuroscience, 2022 - frontiersin.org
The transcriptional regulator nuclear factor kappa B (NF-κB) modulates cellular biological
activity by binding to promoter regions in the nucleus and transcribing various protein …

Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: a lifetime decision analytic …

HY Chan, BFM Wijnen, MHJM Majoie, SMAA Evers… - …, 2022 - Wiley Online Library
Objectives This study was undertaken to estimate the cost‐effectiveness of deep brain
stimulation (DBS) compared with vagus nerve stimulation (VNS) and care as usual (CAU) for …

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

ZM Yi, 1–3, C Wen, T Cai, L Xu, XL Zhong… - Neuropsychiatric …, 2018 - Taylor & Francis
Objective To evaluate the efficacy, safety and economics of levetiracetam (LEV) for epilepsy.
Materials and methods PubMed, Scopus, the Cochrane Library, OpenGrey. eu and …